Integer (ITGR) Set to Announce Quarterly Earnings on Thursday

Integer (NYSE:ITGR) will issue its quarterly earnings data before the market opens on Thursday, July 25th. Analysts expect the company to announce earnings of $1.24 per share for the quarter. Integer has set its FY24 guidance at $5.01-5.43 EPS and its FY 2024 guidance at 5.010-5.430 EPS.Persons that are interested in participating in the company’s earnings conference call can do so using this link.

Integer (NYSE:ITGR) last announced its quarterly earnings data on Thursday, April 25th. The medical equipment provider reported $1.14 earnings per share (EPS) for the quarter, topping the consensus estimate of $1.12 by $0.02. The business had revenue of $414.80 million for the quarter, compared to the consensus estimate of $412.78 million. Integer had a net margin of 6.01% and a return on equity of 11.25%. Integer’s quarterly revenue was up 9.5% on a year-over-year basis. During the same quarter last year, the company posted $0.87 earnings per share. On average, analysts expect Integer to post $5 EPS for the current fiscal year and $6 EPS for the next fiscal year.

Integer Price Performance

NYSE:ITGR opened at $126.11 on Wednesday. The company has a debt-to-equity ratio of 0.76, a current ratio of 3.32 and a quick ratio of 2.01. The stock has a market cap of $4.23 billion, a P/E ratio of 43.64, a PEG ratio of 1.86 and a beta of 1.11. The company has a fifty day moving average price of $119.04 and a 200 day moving average price of $112.95. Integer has a one year low of $69.40 and a one year high of $130.15.

Analyst Upgrades and Downgrades

Several equities research analysts recently weighed in on the stock. Truist Financial initiated coverage on shares of Integer in a research note on Wednesday, May 15th. They issued a “buy” rating and a $137.00 target price for the company. KeyCorp boosted their price objective on Integer from $123.00 to $139.00 and gave the company an “overweight” rating in a research report on Tuesday, April 9th. Bank of America upgraded Integer from a “neutral” rating to a “buy” rating and upped their target price for the company from $105.00 to $135.00 in a research note on Monday, April 15th. Benchmark reiterated a “buy” rating and set a $130.00 price target on shares of Integer in a research note on Friday, May 10th. Finally, Citigroup raised their price objective on shares of Integer from $118.00 to $124.00 and gave the stock a “neutral” rating in a report on Wednesday, May 22nd. Three investment analysts have rated the stock with a hold rating and six have given a buy rating to the company. Based on data from MarketBeat.com, the company presently has a consensus rating of “Moderate Buy” and an average price target of $128.88.

Insider Buying and Selling at Integer

In other news, Director James F. Hinrichs sold 9,603 shares of the company’s stock in a transaction dated Friday, May 24th. The shares were sold at an average price of $122.44, for a total value of $1,175,791.32. Following the sale, the director now owns 7,424 shares of the company’s stock, valued at approximately $908,994.56. The transaction was disclosed in a legal filing with the SEC, which can be accessed through the SEC website. In related news, VP Tommy P. Thomas sold 1,500 shares of the firm’s stock in a transaction on Tuesday, April 30th. The stock was sold at an average price of $114.00, for a total transaction of $171,000.00. Following the completion of the sale, the vice president now directly owns 2,813 shares of the company’s stock, valued at approximately $320,682. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director James F. Hinrichs sold 9,603 shares of the business’s stock in a transaction on Friday, May 24th. The stock was sold at an average price of $122.44, for a total value of $1,175,791.32. Following the completion of the transaction, the director now directly owns 7,424 shares in the company, valued at approximately $908,994.56. The disclosure for this sale can be found here. Over the last three months, insiders sold 17,936 shares of company stock valued at $2,130,937. 2.00% of the stock is currently owned by company insiders.

Integer Company Profile

Integer Holdings Corporation operates as a medical device outsource manufacturer in the United States, Puerto Rico, Costa Rica, and internationally. It operates through two segments, Medical and Non-Medical. The company offers products for interventional cardiology, structural heart, heart failure, peripheral vascular, neurovascular, interventional oncology, electrophysiology, vascular access, infusion therapy, hemodialysis, non-vascular, urology, and gastroenterology procedures.